Find Safinamide Methanesulfonate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Listed Dossiers

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

105RELATED EXCIPIENT COMPANIES

168EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 202825-46-5, Safinamide mesilate, (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate, Pnu-151774e, Nw-1015, Safinamide (mesylate)
Molecular Formula
C18H23FN2O5S
Molecular Weight
398.5  g/mol
InChI Key
YKOCHIUQOBQIAC-YDALLXLXSA-N
FDA UNII
YS90V3DTX0

Safinamide Methanesulfonate
1 2D Structure

Safinamide Methanesulfonate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid
2.1.2 InChI
InChI=1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1
2.1.3 InChI Key
YKOCHIUQOBQIAC-YDALLXLXSA-N
2.1.4 Canonical SMILES
CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
YS90V3DTX0
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (s)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide

2. 2-(4-(3-fluorobenzyloxy)benzylamino)propionamide

3. Fbap Methanesulfonate

4. Fce 26743

5. Fce 28073

6. Fce-26743

7. Fce-28073

8. Nw-1015

9. Pnu 151774e

10. Pnu-151774e

11. Safinamide

12. Safinamide Methanesulfonate

13. Xadago

2.3.2 Depositor-Supplied Synonyms

1. 202825-46-5

2. Safinamide Mesilate

3. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide Methanesulfonate

4. Pnu-151774e

5. Nw-1015

6. Safinamide (mesylate)

7. Safinamide Methanesulfonate

8. Pnu 151774e

9. Safinamide Mesylate [usan]

10. Fce-28073

11. Nw 1015

12. Safinamide Methansulfonate

13. Ys90v3dtx0

14. Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2s)-, Methanesulfonate (1:1)

15. 202825-46-5 (mesylate)

16. Safinamide Mesilate (jan)

17. Safinamide Mesylate (usan)

18. Safinamide Mesilate [jan]

19. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)-amino)propanamide Methanesulfonate

20. Chembl48582

21. (s)-2-[[4-[(3-fluorobenzyl)oxy]benzyl]amino]propanamide Methanesulfonate

22. Unii-ys90v3dtx0

23. Fce-28073(r-isomer)

24. Safinamidemesylate

25. Equfina (tn)

26. Xadago (tn)

27. Safinamide Mesylate Salt

28. Emd 1195686 Mesylate

29. Mls006010740

30. Schembl1665715

31. Dtxsid80942414

32. Hms3884o17

33. Safinamide Mesylate (fce28073)

34. Amy38833

35. Bcp16018

36. Ex-a2640

37. Hy-70057a

38. Mfcd15145475

39. S1472

40. Safinamide Mesilate [who-dd]

41. Akos015902297

42. Ccg-268636

43. Safinamide Methanesulfonate [mi]

44. Safinamide Mesylate [orange Book]

45. Ac-27739

46. As-75602

47. Pnu-151774e,fce28073

48. Smr004701699

49. Safinamide Mesylate Salt, >=98% (hplc)

50. Cs-0006742

51. Sw219452-1

52. D10191

53. J-013174

54. Q27294690

55. (s)-2[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

56. (s)-(+)-2-(4-(3-fluorobenzyloxy) Benzylamino)propanamide, Methanesulfonate

57. (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamidemethanesulfonate

58. (s)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide Methanesulfonate

59. (2s)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic Acid

60. Propanamide, 2-(((4-((3-fluorophenyl)methoxy)phenyl)methyl)amino)-, (s)-, Monomethanesulfonate

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 398.5 g/mol
Molecular Formula C18H23FN2O5S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass398.13117117 g/mol
Monoisotopic Mass398.13117117 g/mol
Topological Polar Surface Area127 Ų
Heavy Atom Count27
Formal Charge0
Complexity438
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Xadago is indicated for the treatment of adult patients with idiopathic Parkinsons disease (PD) as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]
5.2 ATC Code

N04B


EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Safinamide Mesylate IH

Date of Issue : 2025-02-27

Valid Till : 2028-02-26

Written Confirmation Number : WC-511n

Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...

Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Safinamide Mesylate

Date of Issue : 2025-02-27

Valid Till : 2028-02-26

Written Confirmation Number : WC-0511

Address of the Firm : Plot No. 80A, Road No.5, Jawaharlal Nehru Pharma City, E. Bonangi (V), Parawada ...

Biophore

03

Chemicals America
Not Confirmed
arrow
arrow
Chemicals America
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-06-07

Valid Till : 2025-06-25

Written Confirmation Number : WC-0023

Address of the Firm : Survey no. 52,53,58,59,61 to 78,127&128, Pydibhimanvaram Village &Sy.No. 1,2,4t0...

blank

04

Chemicals America
Not Confirmed
arrow
arrow
Chemicals America
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-12-09

Valid Till : 2025-12-03

Written Confirmation Number : WC-0457

Address of the Firm : Sy No 544, 545 & 546, Bhiknoor (V), Bhiknoor (M), Kamareddy-503101, Telangana, I...

blank

05

Chemicals America
Not Confirmed
arrow
arrow
Chemicals America
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-11-02

Valid Till : 2025-07-02

Written Confirmation Number : WC-0182

Address of the Firm : Sy.No.239&240,Dothigudem Village,Pochampally MandalYadadri-Bhuvanagiri,Dist.-508...

blank

06

Chemicals America
Not Confirmed
arrow
arrow
Chemicals America
Not Confirmed

Safinamide Mesylate IH

Date of Issue : 2022-08-31

Valid Till : 2025-08-04

Written Confirmation Number : WC-0127

Address of the Firm : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore -607005

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647455400,"product":"SAFINAMIDE MESYLATE","address":"H.NO.4-7-101, SCIENTIST COLONY, HABSIGUDA, NACHARAM, Contact No: 91","city":"HYDERABAD","supplier":"OPTIMUS DRUGS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"HO CHI MINH C","customer":"UNDISCLOSED","customerCountry":"VIETNAM","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"3000","totalValueFC":"1390.7","currency":"USD","unitRateINR":212000,"date":"17-Mar-2022","totalValueINR":"106000","totalValueInUsd":"1390.7","indian_port":"HYDERABAD AIR","hs_no":"29242990","bill_no":"9025104","productDescription":"API","marketType":"","country":"VIETNAM, DEMOCRATIC REP. OF","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO.4-7-101, SCIENTIST COLONY, HABSIGUDA, NACHARAM, Contact No: 91, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717093800,"product":"SAFINAMIDE MESYLATE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"RONTIS HELLAS S A","customerCountry":"GREECE","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"5000","totalValueFC":"14758","currency":"USD","unitRateINR":410047.66666666669,"date":"31-May-2024","totalValueINR":"1230143","totalValueInUsd":"14758","indian_port":"Hyderabad Air","hs_no":"29241900","bill_no":"1339397","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723487400,"product":"SAFINAMIDE MESYLATE","address":"HOSTER LABS PRIVATE LIMITED","city":"HYDERABAD","supplier":"HOSTER LABS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MYUNGIN PHARM COMLTD","customerCountry":"KOREA, REPUBLIC OF","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"1500","totalValueFC":"4413.2","currency":"USD","unitRateINR":123391.21333333333,"date":"13-Aug-2024","totalValueINR":"370173.64","totalValueInUsd":"4413.2","indian_port":"Hyderabad Air","hs_no":"29242990","bill_no":"3188237","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HOSTER LABS PRIVATE LIMITED, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1747593000,"product":"SAFINAMIDE MESYLATE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"JP BIO CORP","customerCountry":"KOREA, REPUBLIC OF","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1350","totalValueFC":"1308.2","currency":"USD","unitRateINR":111460,"date":"19-May-2025","totalValueINR":"111460","totalValueInUsd":"1308.2","indian_port":"Hyderabad Air","hs_no":"29242990","bill_no":"1963802","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673548200,"product":"SAFINAMIDE MESYLATE","address":"SURVEY NO 91 OPP NAVIN FLOURINE,IN D UDHNA NAVSARI ROAD BHESTAN","city":"SURAT,GUJARAT","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"CTX LIFESCIENCES PRIVATE LTD","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2000","totalValueFC":"6142.4","currency":"USD","unitRateINR":"167400","date":"13-Jan-2023","totalValueINR":"502200","totalValueInUsd":"6142.4","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"4173726","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SURVEY NO 91 OPP NAVIN FLOURINE,IN D UDHNA NAVSARI ROAD BHESTAN"}]
17-Mar-2022
19-May-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 100MG BASE

USFDA APPLICATION NUMBER - 207145

read-more

DOSAGE - TABLET;ORAL - EQ 50MG BASE

USFDA APPLICATION NUMBER - 207145

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Empty Capsules

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US World/Supern

Safinamide Mesylate

Drug Cost (USD) : 2,681,189

Year : 2023

Prescribers : 278

Prescriptions : 1377

blank

02

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 7,191,406

Year : 2023

Prescribers : 672

Prescriptions : 3849

blank

03

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 7,703,748

Year : 2022

Prescribers : 819

Prescriptions : 4678

blank

04

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US World/Supern

Safinamide Mesylate

Drug Cost (USD) : 2,918,297

Year : 2022

Prescribers : 347

Prescriptions : 1721

blank

05

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 7,735,718

Year : 2021

Prescribers : 939

Prescriptions : 5403

blank

06

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US World/Supern

Safinamide Mesylate

Drug Cost (USD) : 3,151,053

Year : 2021

Prescribers : 435

Prescriptions : 2145

blank

07

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 7,308,038

Year : 2020

Prescribers : 997

Prescriptions : 6017

blank

08

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US World/Supern

Safinamide Mesylate

Drug Cost (USD) : 3,228,411

Year : 2020

Prescribers : 509

Prescriptions : 2502

blank

09

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 8,781,629

Year : 2019

Prescribers : 1441

Prescriptions : 8062

blank

10

arrow
AGGSpend
Not Confirmed
arrow
AGGSpend
Not Confirmed

Company : US Worldmeds

Safinamide Mesylate

Drug Cost (USD) : 6,304,633

Year : 2018

Prescribers : 1354

Prescriptions : 6306

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 100 mg

Price Per Pack (Euro) : 125.93

Published in :

Country : Norway

RX/OTC/DISCN :

blank

02

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 100 mg

Price Per Pack (Euro) : 404.67

Published in :

Country : Norway

RX/OTC/DISCN :

blank

03

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 50 mg

Price Per Pack (Euro) : 118.66

Published in :

Country : Norway

RX/OTC/DISCN :

blank

04

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 50 mg

Price Per Pack (Euro) : 380.68

Published in :

Country : Norway

RX/OTC/DISCN :

blank

05

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Price Per Pack (Euro) : 127

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

06

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Price Per Pack (Euro) : 405.12

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

07

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Film-Coated Tablets

Dosage Strength : 50mg

Price Per Pack (Euro) : 121.9

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

08

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Film-Coated Tablets

Dosage Strength : 50mg

Price Per Pack (Euro) : 388.12

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

09

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Safinamide 100Mg 30 Joined' Oral...

Dosage Strength : 30 cpr riv 100 mg

Price Per Pack (Euro) : 130.7

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

10

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Brand Name : Xadago

Switzerland
arrow
AGGSpend
Not Confirmed

Safinamide Methanesulfonate

Dosage Form : Safinamide 50Mg 30 Joined' Oral ...

Dosage Strength : 30 cpr riv 50 mg

Price Per Pack (Euro) : 130.7

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

read-more
read-more

01

Brand Name : Equfina

Safinamide

arrow
AGGSpend
Not Confirmed

Brand Name : Equfina

Japan
arrow
AGGSpend
Not Confirmed

Safinamide

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 31

2022 Revenue in Millions : 35

Growth (%) : -2

blank

02

Brand Name : Equfina

Safinamide

arrow
AGGSpend
Not Confirmed

Brand Name : Equfina

Japan
arrow
AGGSpend
Not Confirmed

Safinamide

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 41

2023 Revenue in Millions : 42

Growth (%) : -3

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8278485

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-08

blank

02

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8283380

Drug Substance Claim :

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-21

blank

03

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8278485

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-08

blank

04

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8076515

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-12-10

blank

05

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8076515

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-12-10

blank

06

arrow
AGGSpend
Not Confirmed

MDD US

United Kingdom
arrow
AGGSpend
Not Confirmed

SAFINAMIDE MESYLATE

US Patent Number : 8283380

Drug Substance Claim :

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-21

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 202825-46-5 / Safinamide Methanesulfonate API manufacturers, exporters & distributors?

Safinamide Methanesulfonate manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Safinamide Methanesulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Safinamide Methanesulfonate manufacturer or Safinamide Methanesulfonate supplier.

PharmaCompass also assists you with knowing the Safinamide Methanesulfonate API Price utilized in the formulation of products. Safinamide Methanesulfonate API Price is not always fixed or binding as the Safinamide Methanesulfonate Price is obtained through a variety of data sources. The Safinamide Methanesulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Safinamide Methanesulfonate

Synonyms

202825-46-5, Safinamide mesilate, (s)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate, Pnu-151774e, Nw-1015, Safinamide (mesylate)

Cas Number

202825-46-5

Unique Ingredient Identifier (UNII)

YS90V3DTX0

Safinamide Manufacturers

A Safinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Safinamide, including repackagers and relabelers. The FDA regulates Safinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Safinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Safinamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Safinamide Suppliers

A Safinamide supplier is an individual or a company that provides Safinamide active pharmaceutical ingredient (API) or Safinamide finished formulations upon request. The Safinamide suppliers may include Safinamide API manufacturers, exporters, distributors and traders.

click here to find a list of Safinamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Safinamide USDMF

A Safinamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Safinamide active pharmaceutical ingredient (API) in detail. Different forms of Safinamide DMFs exist exist since differing nations have different regulations, such as Safinamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Safinamide DMF submitted to regulatory agencies in the US is known as a USDMF. Safinamide USDMF includes data on Safinamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Safinamide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Safinamide suppliers with USDMF on PharmaCompass.

Safinamide JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Safinamide Drug Master File in Japan (Safinamide JDMF) empowers Safinamide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Safinamide JDMF during the approval evaluation for pharmaceutical products. At the time of Safinamide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Safinamide suppliers with JDMF on PharmaCompass.

Safinamide KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Safinamide Drug Master File in Korea (Safinamide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Safinamide. The MFDS reviews the Safinamide KDMF as part of the drug registration process and uses the information provided in the Safinamide KDMF to evaluate the safety and efficacy of the drug.

After submitting a Safinamide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Safinamide API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Safinamide suppliers with KDMF on PharmaCompass.

Safinamide WC

A Safinamide written confirmation (Safinamide WC) is an official document issued by a regulatory agency to a Safinamide manufacturer, verifying that the manufacturing facility of a Safinamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Safinamide APIs or Safinamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Safinamide WC (written confirmation) as part of the regulatory process.

click here to find a list of Safinamide suppliers with Written Confirmation (WC) on PharmaCompass.

Safinamide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Safinamide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Safinamide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Safinamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Safinamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Safinamide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Safinamide suppliers with NDC on PharmaCompass.

Safinamide GMP

Safinamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Safinamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Safinamide GMP manufacturer or Safinamide GMP API supplier for your needs.

Safinamide CoA

A Safinamide CoA (Certificate of Analysis) is a formal document that attests to Safinamide's compliance with Safinamide specifications and serves as a tool for batch-level quality control.

Safinamide CoA mostly includes findings from lab analyses of a specific batch. For each Safinamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Safinamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Safinamide EP), Safinamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Safinamide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty